These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Depostat for benign prostatic hyperplasia? Drug Ther Bull; 1973 Sep; 11(19):75-6. PubMed ID: 4130364 [No Abstract] [Full Text] [Related]
11. [Antiandrogen therapy of benign prostatic hyperplasia--review of the agents evaluation of the clinical results]. Kanimoto Y; Okada K Hinyokika Kiyo; 1991 Nov; 37(11):1423-8. PubMed ID: 1722627 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Depostat in prostatic adenoma on the ground of clinical and sphincterotonometric studies. Makrigiannis D; Gaca A Int Urol Nephrol; 1971; 3(1):21-9. PubMed ID: 4117491 [No Abstract] [Full Text] [Related]
13. [Monitoring the effectiveness of conservative treatment of benign prostatic hypertrophy by means of uroflowmetry]. Tunn U; Senge T Z Urol Nephrol; 1978 Aug; 71(8):521-8. PubMed ID: 83057 [TBL] [Abstract][Full Text] [Related]
14. [Influence of anti-androgen therapy for prostatic hypertrophy on lipid metabolism]. Iguchi H; Ikeuchi T; Kai Y; Yoshida H Hinyokika Kiyo; 1994 Mar; 40(3):215-9. PubMed ID: 7513937 [TBL] [Abstract][Full Text] [Related]
15. Mode of action of progesterone, gestonorone capronate (Depostat) and cyproterone acetate (Androcur) on the metabolism of testosterone in human prostatic adenoma: in vitro and in vivo investigations. Orestano F; Altwein JE; Knapstein P; Bandhauer K J Steroid Biochem; 1975 Jun; 6(6):845-51. PubMed ID: 1177428 [No Abstract] [Full Text] [Related]
16. [Influence of gestonoron-capronate (GC) upon uptake and metabolism of H3-testosteron in benign prostatic hypertrophy (BPH): in vivo-experiments (author's transl)]. Orestano F; Bandhauer K; Altwein JE Urologe A; 1974 Nov; 13(6):289-92. PubMed ID: 4141158 [No Abstract] [Full Text] [Related]
17. The treatment of benign enlargement of the prostate with nor progesterone caproate (primostat). Subbiah N; Mortensen J Aust N Z J Surg; 1973 Feb; 42(3):304-7. PubMed ID: 4129814 [No Abstract] [Full Text] [Related]
18. [Current therapy of benign prostatic hypertrophy]. Rist M Schweiz Rundsch Med Prax; 1986 Jul; 75(29):875-6. PubMed ID: 2426754 [No Abstract] [Full Text] [Related]
19. Antiandrogens and prostatic tumours (experimental base and clinical use). Neumann R; Schenck B; Senge T; Richter KD Prog Clin Biol Res; 1976; 6():169-88. PubMed ID: 66688 [No Abstract] [Full Text] [Related]